Skip to main content
Top
Published in: Breast Cancer Research 2/2006

01-04-2006 | Review

Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?

Authors: Ruth Warren, Asha Eleti

Published in: Breast Cancer Research | Issue 2/2006

Login to get access

Abstract

Overdiagnosis is diagnosis of cancers that would not present within the life of the patient and is one of the downsides of screening. This applies to low-grade ductal carcinoma in situ and some small grade 1 invasive cancers. Radiologists are responsible for cancer diagnosis, but at the time of diagnosis they cannot determine whether a particular low-grade diagnosis is one to which the definition of overdiagnosis applies. Overdiagnosis is likely to be driven by technological developments, including digital mammography, computer-aided detection and improved biopsy techniques. It is also driven by the patient's fear that cancer will be missed and the doctor's fear of litigation. It is therefore an issue of importance for radiologists, presenting them with difficult fine-tuned decisions in every assessment clinic that are ultimately counted later by those who evaluate their screening.
Literature
1.
go back to reference Moss SM: Overdiagnosis and over treatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005, 7: 230-234. 10.1186/bcr1314.CrossRefPubMedPubMedCentral Moss SM: Overdiagnosis and over treatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005, 7: 230-234. 10.1186/bcr1314.CrossRefPubMedPubMedCentral
2.
go back to reference Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC: The natural history of breast carcinoma: what have we learned from screening?. Cancer. 1999, 86: 449-462. 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q.CrossRefPubMed Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC: The natural history of breast carcinoma: what have we learned from screening?. Cancer. 1999, 86: 449-462. 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q.CrossRefPubMed
3.
go back to reference Taplin SH, Ichikawa LE, Kerlikowske K, Ernster VL, Rosenberg RD, Yankaskas BC, Carney PA, Geller BM, Urban N, Dignan MB, et al: Concordance of breast imaging reporting and data systemassessments and management recommendations in screening mammography. Radiology. 2002, 222: 529-535.CrossRefPubMed Taplin SH, Ichikawa LE, Kerlikowske K, Ernster VL, Rosenberg RD, Yankaskas BC, Carney PA, Geller BM, Urban N, Dignan MB, et al: Concordance of breast imaging reporting and data systemassessments and management recommendations in screening mammography. Radiology. 2002, 222: 529-535.CrossRefPubMed
4.
go back to reference Welch H, Black W: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of breast: how much more breast cancer can we find?. Ann Intern Med. 1997, 127: 1023-1028.CrossRefPubMed Welch H, Black W: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of breast: how much more breast cancer can we find?. Ann Intern Med. 1997, 127: 1023-1028.CrossRefPubMed
5.
go back to reference Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA: Mammographic tumor features can predict long-term outcomes reliably in women with 1–14-mm invasive breastcarcinoma. Cancer. 2004, 101: 1745-1759. 10.1002/cncr.20582.CrossRefPubMed Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA: Mammographic tumor features can predict long-term outcomes reliably in women with 1–14-mm invasive breastcarcinoma. Cancer. 2004, 101: 1745-1759. 10.1002/cncr.20582.CrossRefPubMed
6.
go back to reference Erbas B, Provenzano E, Armes J, Gertig D: The naturalhistory of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2005. Erbas B, Provenzano E, Armes J, Gertig D: The naturalhistory of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2005.
7.
go back to reference Evans A, Blanks R: Should breast screening programmes limit their detection of ductal carcinoma in situ?. Clin Radiol. 2002, 57: 1086-1089. 10.1053/crad.2002.1097.CrossRefPubMed Evans A, Blanks R: Should breast screening programmes limit their detection of ductal carcinoma in situ?. Clin Radiol. 2002, 57: 1086-1089. 10.1053/crad.2002.1097.CrossRefPubMed
8.
go back to reference Warren R, Allgood P, Hunnam G, Godward S, Duffy S: An audit of assessment procedures in women who develop breast cancer after a negative result. J Med Screen. 2004, 11: 180-186. 10.1258/0969141042467395.CrossRefPubMed Warren R, Allgood P, Hunnam G, Godward S, Duffy S: An audit of assessment procedures in women who develop breast cancer after a negative result. J Med Screen. 2004, 11: 180-186. 10.1258/0969141042467395.CrossRefPubMed
9.
go back to reference Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, et al: Diagnostic performance of digital versus film mammography for breast-cancerscreening. N Engl J Med. 2005, 353: 1773-1783. 10.1056/NEJMoa052911.CrossRefPubMed Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, et al: Diagnostic performance of digital versus film mammography for breast-cancerscreening. N Engl J Med. 2005, 353: 1773-1783. 10.1056/NEJMoa052911.CrossRefPubMed
10.
go back to reference Birdwell R, Bandodkar P, Ikeda D: Computer-aideddetection with screening mammography in a university hospital setting. Radiology. 2005, 236: 451-457.CrossRefPubMed Birdwell R, Bandodkar P, Ikeda D: Computer-aideddetection with screening mammography in a university hospital setting. Radiology. 2005, 236: 451-457.CrossRefPubMed
11.
go back to reference Khoo L, Taylor P, Given-Wilson R: Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology. 2005, 237: 444-449.CrossRefPubMed Khoo L, Taylor P, Given-Wilson R: Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology. 2005, 237: 444-449.CrossRefPubMed
12.
go back to reference Heywang-Kobrunner S, Schreer I, Decker T, Bocker W: Interdisciplinary consensus on the use and technique of vacuum-assisted stereotactic breast biopsy. Eur J Radiol. 2003, 47: 232-236. 10.1016/S0720-048X(02)00196-1.CrossRefPubMed Heywang-Kobrunner S, Schreer I, Decker T, Bocker W: Interdisciplinary consensus on the use and technique of vacuum-assisted stereotactic breast biopsy. Eur J Radiol. 2003, 47: 232-236. 10.1016/S0720-048X(02)00196-1.CrossRefPubMed
13.
go back to reference Buchanan C, Morris E, Dorn P, Borgen P, Van Zee K: Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005, 12: 1045-1053. 10.1245/ASO.2005.03.520.CrossRefPubMed Buchanan C, Morris E, Dorn P, Borgen P, Van Zee K: Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005, 12: 1045-1053. 10.1245/ASO.2005.03.520.CrossRefPubMed
14.
go back to reference Viehweg P, Bernerth T, Kiechle M, Buchmann J, Heinig A, Koelbl H, Laniado M, Heywang-Kobrunner SH: MR-guided intervention in women with a family history of breast cancer. Eur J Radiol. 2006, 57: 81-89. 10.1016/j.ejrad.2005.09.004.CrossRefPubMed Viehweg P, Bernerth T, Kiechle M, Buchmann J, Heinig A, Koelbl H, Laniado M, Heywang-Kobrunner SH: MR-guided intervention in women with a family history of breast cancer. Eur J Radiol. 2006, 57: 81-89. 10.1016/j.ejrad.2005.09.004.CrossRefPubMed
15.
go back to reference Sneige N, Lim S, Whitman G, Krishnamurthy S, Sahin A, Smith T, Stelling CB: Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast micro-calcifications. Considerations for surgical excision. Am J Clin Pathol. 2003, 119: 248-253. 10.1309/0GYV-4F2L-LJAV-4GFN.CrossRefPubMed Sneige N, Lim S, Whitman G, Krishnamurthy S, Sahin A, Smith T, Stelling CB: Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast micro-calcifications. Considerations for surgical excision. Am J Clin Pathol. 2003, 119: 248-253. 10.1309/0GYV-4F2L-LJAV-4GFN.CrossRefPubMed
16.
go back to reference Domenighetti G, D'Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, Zwahlen M: Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003, 32: 816-821. 10.1093/ije/dyg257.CrossRefPubMed Domenighetti G, D'Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, Zwahlen M: Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003, 32: 816-821. 10.1093/ije/dyg257.CrossRefPubMed
18.
go back to reference Hofvind S, Skaane P, Vitak B, Wang H, Thoresen S, Eriksen L, Bjorndal H, Braaten A, Bjurstam N: Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program. Radiology. 2005, 237: 437-443.CrossRefPubMed Hofvind S, Skaane P, Vitak B, Wang H, Thoresen S, Eriksen L, Bjorndal H, Braaten A, Bjurstam N: Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program. Radiology. 2005, 237: 437-443.CrossRefPubMed
19.
go back to reference Elmore JG, Taplin SH, Barlow WE, Cutter GR, D'Orsi CJ, Hen-drick RE, Abraham LA, Fosse JS, Carney PA: Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. Radiology. 2005, 236: 37-46.CrossRefPubMedPubMedCentral Elmore JG, Taplin SH, Barlow WE, Cutter GR, D'Orsi CJ, Hen-drick RE, Abraham LA, Fosse JS, Carney PA: Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. Radiology. 2005, 236: 37-46.CrossRefPubMedPubMedCentral
20.
go back to reference Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M, Cost Work Group of the U.S. Preventive Services Task Force: The cost-effectiveness of screening mam-mography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003, 139: 835-842.CrossRefPubMed Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M, Cost Work Group of the U.S. Preventive Services Task Force: The cost-effectiveness of screening mam-mography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003, 139: 835-842.CrossRefPubMed
21.
go back to reference Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998, 90: 1138-1145. 10.1093/jnci/90.15.1138.CrossRefPubMed Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998, 90: 1138-1145. 10.1093/jnci/90.15.1138.CrossRefPubMed
22.
go back to reference Watson E, Henderson B, Brett J, Bankhead C, Austoker J: The psychological impact of mammographic screening on women with a family history of breast cancer: a systematic review. Psychooncology. 2005, 14: 939-948. 10.1002/pon.903.CrossRefPubMed Watson E, Henderson B, Brett J, Bankhead C, Austoker J: The psychological impact of mammographic screening on women with a family history of breast cancer: a systematic review. Psychooncology. 2005, 14: 939-948. 10.1002/pon.903.CrossRefPubMed
Metadata
Title
Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?
Authors
Ruth Warren
Asha Eleti
Publication date
01-04-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1396

Other articles of this Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine